NCT00704236View on ClinicalTrials.gov

Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

February 29, 2008

Conditions
Type 2 Diabetes
Interventions
DRUG

Coptis Chinensis, Astragalus mambranesceus, Lonicera Japonica (Traditional Chinese Treatment)

50 mg of Coptis Chinensis, 30 mg of Astragalus mambranesceus and 120 mg of Lonicera Japonica

DRUG

Placebo

Trial Locations (1)

200025

Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT00704236 - Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter